Four polymorphisms of cholesteryl ester transfer protein gene and coronary stenosis in a Tunisian population

Journal of Cardiovascular Medicine

Volumn 13, Issue 9, 2012, Pages 546-553

  Rejeb, Jihène ^a   Omezzine, Asma ^a   Boumaiza, Imen ^a   Rebhi, Lamia ^a   Rejeb, Nabila Ben ^a   Nabli, Naoufel ^a   Abdelaziz, Ahmed Ben ^a   Boughzala, Essia ^a   Bouslama, Ali ^a  

^a SAHLOUL UNIVERSITY HOSPITAL   (Tunisia)

Author keywords

cholesteryl ester transfer protein polymorphisms; coronary stenosis; haplotype; Tunisian

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ALLELE; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY OBSTRUCTION; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL;

ALLELES; APOLIPOPROTEINS B; ATHEROSCLEROSIS; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; CONFIDENCE INTERVALS; CORONARY STENOSIS; DNA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; ODDS RATIO; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; RISK FACTORS; TUNISIA;

EID: 84865119326     PISSN: 15582027     EISSN: 15582035     Source Type: Journal    
DOI: 10.2459/JCM.0b013e3283569b24     Document Type: Article

References (53)

1. Miller GJ, Miller NE. Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease. Lancet 1975; 1:16-19.
2. Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA 1986; 256:2835-2838. (Pubitemid 17178361)
3. Sampietro T, Bigazzi F, Puntoni M, et al. Low high-density lipoprotein predicts death in patients with mild left ventricular dysfunction regardless of coronary atherosclerosis. J Cardiovasc Med 2009; 10:898-905.
4. Lewis GF, Rader DJ. New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ Res 2005; 96:1221-1232. (Pubitemid 40962099)
5. Tall AR. Plasma cholesteryl ester transfer protein. J Lipid Res 1993; 34:1255-1274. (Pubitemid 23230305)
6. Barter PJ, Rye KA. Cholesteryl ester transfer protein, high density lipoprotein and arterial disease. Curr Opin Lipidol 2001; 12:377-382. (Pubitemid 32675497)
7. Fielding CJ, Havel RJ. Cholesteryl ester transfer protein: friend or foe? J Clin Invest 1996; 97:2687-2688. (Pubitemid 26197083)
8. Stein O, Stein Y. Lipid transfer proteins (LTP) and atherosclerosis. Atherosclerosis 2005; 178:217-230. (Pubitemid 40193434)
9. Drayna D, Jarnagin AS, McLean J, et al. Cloning and sequencing of human cholesteryl ester transfer protein cDNA. Nature 1987; 327:632-634. (Pubitemid 17086900)
10. Agellon LB, Quinet EM, Gillette TG, et al. Organization of human cholesteryl ester transfer protein gene. Biochemistry 1990; 29:1372-1376. (Pubitemid 20063363)
11. Callen DF, Hildebrand CE, Reeders S. Report of the second international workshop on human chromosome 16 mapping. Cytogenet Cell Genet 1992; 60:158-167.
12. Corbex M, Poirier O, Fumeron F, et al. Extensive association analysis between the CETP gene and coronary heart disease phenotypes reveals several putative functional polymorphisms and gene-environment interaction. Genet Epidemiol 2000; 19:64-80. (Pubitemid 30445638)
13. Blankenberg S, Rupprecht HJ, Bickel C, et al. Common genetic variation of the cholesteryl ester transfer protein gene strongly predicts future cardiovascular death in patients with coronary artery disease. J Am Coll Cardiol 2003; 41:1983-1989. (Pubitemid 36677119)
14. Thompson A, Di Angelantonio E, Sarwar N, et al. Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk. JAMA 2008; 299:2777-2788. (Pubitemid 351846853)
15. Boekholdt SM, Thompson JF. Natural genetic variation as a tool in understanding the role of CETP in lipid levels and disease. J Lipid Res 2003; 44:1080-1093. (Pubitemid 37279626)
16. Boekholdt SM, Kuivenhoven JA, Hovingh GK, Jukema JW, Kastelein JJ, van Tol A. CETP gene variation: relation to lipid parameters and cardiovascular risk. Curr Opin Lipidol 2004; 15:393-398. (Pubitemid 39061618)
17. Rejeb J, Omezzine A, Rebhi L, et al. Association of the cholesteryl ester transfer protein Taq1 B2B2 genotype with higher high-density lipoprotein cholesterol concentrations and lower risk of coronary artery disease in a Tunisian population. Arch Cardiovasc Dis 2008; 101:629-636.
18. Okumura K, Matsui H, Kamiya H, et al. Differential effect of two common polymorphisms in the cholesteryl ester transfer protein gene on low-density lipoprotein particle size. Atherosclerosis 2002; 161:425-431. (Pubitemid 34219197)
19. Kakko S, Tamminen M, Pa È iva È nsalo M, et al. Cholesteryl ester transfer protein gene polymorphisms are associated with carotid atherosclerosis in men. Eur J Clin Invest 2000; 30:18-25. (Pubitemid 30071853)
20. Gudnason V, Thormar K, Humphries SE. Interaction of the cholesteryl ester transfer protein I405V polymorphism with alcohol consumption in smoking and nonsmoking healthy men, and the effect on plasma HDL cholesterol and apoAI concentration. Clin Genet 1997; 51:15-21. (Pubitemid 27116893)
21. Bruce C, Sharp DS, Tall AR. Relationship of HDL and coronary heart disease to a common amino acid polymorphism in the cholesteryl ester transfer protein in men with and without hypertriglyceridemia. J Lipid Res 1998; 39:1071-1078. (Pubitemid 28222013)
22. Agerholm-Larsen B, Nordestgaard BG, Steffensen R, Jensen G, Tybjaerg-Hansen A. Elevated HDL cholesterol is a risk factor for ischemic heart disease in white women when caused by a common mutation in the cholesteryl ester transfer protein gene. Circulation 2000; 101:1907-1912. (Pubitemid 30225270)
23. Agerholm-Larsen B, Tybjaerg-Hansen A, Schnohr P, Steffensen R, Nordestgaard BG. Common cholesteryl ester transfer protein mutations, decreased HDL cholesterol, and possible decreased risk of ischemic heart disease: The Copenhagen City Heart Study. Circulation 2000; 102:2197-2203.
24. Kakko S, Tamminen M, KesaÈ niemi YA, Savolainen MJ. R451Q mutation in the cholesteryl ester transfer protein (CETP) gene is associated with high plasma CETP activity. Atherosclerosis 1998; 136:233-240. (Pubitemid 28133411)
25. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15:539-553. (Pubitemid 28319935)
26. Chobanian AV, Bakris GL, Black HR, et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289:2560-2572. (Pubitemid 37430158)
27. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285:2486-2497.
28. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18:499-502.
29. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16:1215.
30. Fumeron F, Betoulle D, Luc G, et al. Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma highdensity lipoprotein and the risk of myocardial infarction. J Clin Invest 1995; 96:1664-1671.
31. Yoo J, Seo B, Kim Y. SNP analyzer: a web-based integrated workbench for single-nucleotide polymorphism analysis. Nucleic Acids Res 2005; 33:W483-W488. (Pubitemid 44529967)
32. Barter P. CETP and atherosclerosis. Arterioscler Thromb Vasc Biol 2000; 20:2029-2031.
33. Polk D, Shah PK. Cholesterol ester transfer protein (CETP) and atherosclerosis. Drug Discov Today: Ther Strateg 2007; 4:137-145.
34. Wu JH, Lee YT, Hsu HC, Hsieh LL. Influence of CETP gene variation on plasma lipid levels and coronary heart disease: a survey in Taiwan. Atherosclerosis 2001; 159:451-458. (Pubitemid 33127259)
35. Ghatreh Samani K, Noori M, Rohbani Nobar M, Hashemzadeh Chaleshtori M, Farrokhi E, Darabi Amin M. I405V and-629C/A polymorphisms of the cholesteryl ester transfer protein gene in patients with coronary artery disease. Iran Biomed J 2009; 13:103-108.
36. Kolovou GD, Anagnostopoulou KK, Karyofillis P, et al. Cholesteryl ester transfer protein gene polymorphisms and severity of coronary stenosis. Clin Invest Med 2006; 29:14-19.
37. Padmaja N, Kumar RM, Balachander J, Adithan C. Cholesteryl ester transfer protein TaqIB,-629CA and I405 V polymorphisms and risk of coronary heart disease in an Indian population. Clin Chim Acta 2009; 402:139-145.
38. Tsai MY, Johnson C, Kao WH, et al. Cholesteryl ester transfer protein genetic polymorphisms, HDL cholesterol, and subclinical cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis 2008; 200:359-367.
39. Ordovas JM, Cupples LA, Corella D, et al. Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingam study. Arterioscler Thromb Vasc Biol 2000; 20:1323-1329. (Pubitemid 30262934)
40. Borggreve SE, Hillege HL, Bruce HR, et al. An increased coronary risk is paradoxically associated with common cholesteryl ester transfer protein gene variations that relate to higher HDL cholesterol: a population based study. J Clin Endocrin Metab 2006; 91:3382-3388. (Pubitemid 44402108)
41. Dogru-Abbasoglu S, Parildar-Karpuzoglu H, Depboylu B, Cine N, Uysal M, Aykaç-Toker G. I405V and TaqIB polymorphisms of the cholesteryl ester transfer protein and their relation to serum lipid and lipoprotein levels in a Turkish population. Cell Biochem Funct 2009; 27:76-80.
42. Kauma H, Savolainen MJ, Heikkila E, et al. Sex difference in the regulation of plasma high density lipoprotein cholesterol by genetic and environmental factors. Hum Genet 1996; 97:156-162. (Pubitemid 26034778)
43. Freeman DJ, Griffin BA, Holmes AP, et al. Regulation of plasma HDL cholesterol and subfraction distribution by genetic and environmental factors. Associations between TaqIB RFLP in the CETP gene and smoking and obesity. Arterioscler Thromb 1994; 14:336-344.
44. Ruan X, Ma L, Wang S, et al. Association of two CETP polymorphisms with HDL levels in the Chinese obese population. Obesity 2009; 17:2196-2201.
45. Jensen MK, Mukamal KJ, Overvad K, Rimm EB. Alcohol consumption, TaqIB polymorphism of cholesteryl ester transfer protein, high-density lipoprotein cholesterol, and risk of coronary heart disease in men and women. Eur Heart J 2008; 29:104-112.
46. Kakko S, Tamminen M, Kesä niemi YA, et al. R451Q mutation in the cholesteryl ester transfer protein (CETP) gene is associated with high plasma CETP activity. Atherosclerosis 1998; 136:233-240. (Pubitemid 28133411)
47. Watts GF, Riches FM, Humphries SE, et al. Genotypic associations of the hepatic secretion of VLDL apolipoprotein B-100 in obesity. J Lipid Res 2000; 41:481-488. (Pubitemid 30183631)
48. Lamarche B, Moorjani S, Lupien PJ, et al. Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Québec Cardiovascular Study. Circulation 1996; 94:273-278. (Pubitemid 26266109)
49. Brown ML, Inazu A, Hesler CB, et al. Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins. Nature 1989; 342:448-451. (Pubitemid 19277523)
50. Inazu A, Brown ML, Hesler CB, et al. Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. N Engl J Med 1990; 323:1234-1238. (Pubitemid 20366528)
51. Westerterp M, van der Hoogt CC, de Haan W, et al. Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE-3-Leiden mice. Arterioscler Thromb Vasc Biol 2006; 26:2552-2559. (Pubitemid 44607480)
52. Larsen AB, Nordestgaard BG, Steffensen R, et al. Elevated HDL cholesterol is a risk factor for ischemic heart disease in white women when caused by a common mutation in the cholesteryl ester transfer protein gene. Circulation 2000; 25:1907-1912. (Pubitemid 30225270)
53. Isaacs A, Sayed-Tabatabaei FA, Hofman A, et al. The cholesteryl ester transfer protein I405V polymorphism is associated with increased high-density lipoprotein levels and decreased risk of myocardial infarction: the Rotterdam Study. Eur J Cardiovasc Prev Rehabil 2007; 14:419-421. (Pubitemid 46945566)